Calligaro 2015.
Study characteristics | ||
Methods | Individual randomized controlled trial in ICUs in four hospitals. | |
Participants | Participants: people who were mechanically ventilated, and suspected of having tuberculosis, 18 years old and older, admitted between 1 Aug 2010 and 31 July 2013. with no tuberculosis treatment in the previous 60 days Female: 40% in the Xpert arm, 41% in the smear microscopy arm HIV infection: 27% Xpert, 32% smear Settings: intensive care units (ICUs) in four tertiary and secondary hospitals in Cape Town Country: South Africa Sample size: 317 participants in total |
|
Interventions | Smear and culture (control), or Xpert MTB/RIF and culture (intervention) of tracheal aspirate samples | |
Outcomes |
Primary outcome: proportion of culture‐positive participants started on anti‐tuberculous treatment in each trial group 48 hrs after enrolment Secondary outcomes
|
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Use of block size of 10, by computer‐generated allocation list |
Allocation concealment (selection bias) | Low risk | Allocation list was kept centrally by the data manager, a nurse contacted the data manager each time an eligible participant was identified |
Baseline characteristics similar (selection bias) | Low risk | No substantial differences observed |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Laboratory staff were blinded to clinical and microbiological details of the participants. Participants and clinicians were not blinded to the test used. |
Protection against contamination (performance bias) | Low risk | Allocation and assignment of the group was done centrally, by a data manager, after a nurse called following availability of eligible participants. No risk of contamination |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Assessment of the outcome was done using study staff who were not blinded, but the outcome was clear. |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | The proportions of loss to follow‐up were 29% in smear, and 8% in the Xpert MTB/RIF groups. |
Selective reporting (reporting bias) | Low risk | All outcomes in the methods section were reported |
Other bias | Low risk | not detected |